Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity

Cited 188 time in webofscience Cited 0 time in scopus
  • Hit : 307
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorKim, Tae Hyungko
dc.contributor.authorJiang, Hai Huako
dc.contributor.authorYoun, Yu Seokko
dc.contributor.authorPark, Chan Woongko
dc.contributor.authorTak, Kyung Kookko
dc.contributor.authorLee, Seulkiko
dc.contributor.authorKim, Hyungjunko
dc.contributor.authorJon, Sangyongko
dc.contributor.authorChen, Xiaoyuanko
dc.contributor.authorLee, Kang Choonko
dc.date.accessioned2013-03-12T22:15:44Z-
dc.date.available2013-03-12T22:15:44Z-
dc.date.created2012-07-09-
dc.date.created2012-07-09-
dc.date.issued2011-01-
dc.identifier.citationINTERNATIONAL JOURNAL OF PHARMACEUTICS, v.403, no.1-2, pp.285 - 291-
dc.identifier.issn0378-5173-
dc.identifier.urihttp://hdl.handle.net/10203/103693-
dc.description.abstractCurcumin (CCM), a yellow natural polyphenol extracted from turmeric (Curcuma longa), has potent anticancer properties as has been demonstrated in various human cancer cells. However, the widespread clinical application of this efficient agent in cancer and other diseases has been limited by its poor aqueous solubility and bioavailability. In this study, we prepared novel CCM-loaded human serum albumin (HSA) nanoparticles (CCM-HSA-NPs) for intravenous administration using albumin bound technology. Field emission scanning electron microscopy (FE-SEM) and dynamic light scattering (DLS) investigation confirmed a narrow size distribution in the 130-150 nm range. Furthermore, CCM-HSA-NPs showed much greater water solubility (300-fold) than free CCM, and on storage, the biological activity of CCM-HSA-NPs was preserved with negligible activity loss. In vivo distributions and vascular endothelial cells transport studies demonstrated the superiority of CCM-HSA-NPs over CCM. Amounts of CCM in tumors after treatment with CCM-HSA-NPs were about 14 times higher at 1 h after injection than that achieved by CCM. Furthermore, vascular endothelial cell binding of CCM increased 5.5-fold, and transport of CCM across a vascular endothelial cell monolayer by Transwell testing was 7.7-fold greater for CCM-HSA-NPs than CCM. Finally, in vivo antitumor tests revealed that CCM-HSA-NPs (10 or 20 mg/kg) had a greater therapeutic effect (50% or 66% tumor growth inhibition vs. PBS-treated controls) than CCM (18% inhibition vs. controls) in tumor xenograft HCT116 models without inducing toxicity. We attribute this potent antitumor activity of CCM-HSA-NPs to enhanced water solubility, increased accumulation in tumors, and an ability to traverse vascular endothelial cell. (C) 2010 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.subjectENDOTHELIAL-CELLS-
dc.subjectIN-VIVO-
dc.subjectCONTRAST AGENT-
dc.subjectCREMOPHOR-FREE-
dc.subjectDRUG-DELIVERY-
dc.subjectPHASE-I-
dc.subjectPACLITAXEL-
dc.subjectTRANSPORT-
dc.subjectEFFICACY-
dc.subjectABI-007-
dc.titlePreparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity-
dc.typeArticle-
dc.identifier.wosid000286557500035-
dc.identifier.scopusid2-s2.0-78650169146-
dc.type.rimsART-
dc.citation.volume403-
dc.citation.issue1-2-
dc.citation.beginningpage285-
dc.citation.endingpage291-
dc.citation.publicationnameINTERNATIONAL JOURNAL OF PHARMACEUTICS-
dc.identifier.doi10.1016/j.ijpharm.2010.10.041-
dc.contributor.localauthorJon, Sangyong-
dc.contributor.nonIdAuthorKim, Tae Hyung-
dc.contributor.nonIdAuthorJiang, Hai Hua-
dc.contributor.nonIdAuthorYoun, Yu Seok-
dc.contributor.nonIdAuthorPark, Chan Woong-
dc.contributor.nonIdAuthorTak, Kyung Kook-
dc.contributor.nonIdAuthorLee, Seulki-
dc.contributor.nonIdAuthorKim, Hyungjun-
dc.contributor.nonIdAuthorChen, Xiaoyuan-
dc.contributor.nonIdAuthorLee, Kang Choon-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorCurcumin-
dc.subject.keywordAuthorSolubility-
dc.subject.keywordAuthorNanoparticle-
dc.subject.keywordAuthorHuman serum albumin-
dc.subject.keywordAuthorAntitumor-
dc.subject.keywordPlusENDOTHELIAL-CELLS-
dc.subject.keywordPlusIN-VIVO-
dc.subject.keywordPlusCONTRAST AGENT-
dc.subject.keywordPlusCREMOPHOR-FREE-
dc.subject.keywordPlusDRUG-DELIVERY-
dc.subject.keywordPlusPHASE-I-
dc.subject.keywordPlusPACLITAXEL-
dc.subject.keywordPlusTRANSPORT-
dc.subject.keywordPlusEFFICACY-
dc.subject.keywordPlusABI-007-
Appears in Collection
BS-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 188 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0